Hydroxyurea and Lumigan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydroxyurea (hydroxyurea) and Lumigan (bimatoprost). Common drug interactions include haemorrhage among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Hydroxyurea and Lumigan. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Hydroxyurea?

Hydroxyurea has active ingredients of hydroxyurea. It is often used in polycythemia vera. eHealthMe is studying from 17,240 Hydroxyurea users. Check the latest studies of Hydroxyurea.

What is Lumigan?

Lumigan has active ingredients of bimatoprost. It is often used in glaucoma. eHealthMe is studying from 20,478 Lumigan users. Check the latest studies of Lumigan.

On Jul, 07, 2026

39 people who take Hydroxyurea and Lumigan together, and have interactions are studied.

Hydroxyurea and Lumigan drug interactions.

What are the common drug interactions of Hydroxyurea and Lumigan, by gender? *:

female:

Haemorrhage (bleeding)
Weight decreased
Abdominal distension
Arrhythmia (irregular heartbeat)
Blood sodium decreased
Chest pain
Contusion (a type of hematoma of tissue in which capillaries)
Decreased appetite
Dysgeusia (disorder of the sense of taste)
Dyspnoea (difficult or laboured respiration)

male:

Dyspnoea (difficult or laboured respiration)
Abdominal discomfort
Borrelia test positive
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac failure congestive
Cellulitis (infection under the skin)
Chills (felling of cold)
Chronic kidney disease
Dysgeusia (disorder of the sense of taste)
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)

What are the common drug interactions of Hydroxyurea and Lumigan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Dyspnoea (difficult or laboured respiration)
Dysgeusia (disorder of the sense of taste)
Contusion (a type of hematoma of tissue in which capillaries)
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haematological malignancy (cancer that affect blood, bone marrow, and lymph nodes)
Haemoglobin decreased
Haemorrhage (bleeding)
Head injury

What are the existing conditions these people have? *

Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 19 people, 48.72%
Primary Myelofibrosis (primary disorder of the bone marrow): 11 people, 28.21%
Pain: 3 people, 7.69%
Essential Thrombocythaemia (chronic blood cancer): 3 people, 7.69%
Diabetes: 3 people, 7.69%
Cardiac Failure Congestive: 3 people, 7.69%
Cardiac Disorder: 3 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxyurea and Lumigan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously